178 related articles for article (PubMed ID: 33587847)
1. Association Between Interleukin-6 and Head and Neck Squamous Cell Carcinoma: A Systematic Review.
Uz U; Eskiizmir G
Clin Exp Otorhinolaryngol; 2021 Feb; 14(1):50-60. PubMed ID: 33587847
[TBL] [Abstract][Full Text] [Related]
2. IL-1/IL-1R Signaling in Head and Neck Cancer.
Niklander SE; Murdoch C; Hunter KD
Front Oral Health; 2021; 2():722676. PubMed ID: 35048046
[TBL] [Abstract][Full Text] [Related]
3. The primary site of head and neck squamous cell carcinoma predicts survival benefits of EGFR inhibitors: A systematic review and meta-analysis.
Nie D; Wang X; Sun M; Feng Z; Pei F; Liu W; Wang Z; Han F
Radiother Oncol; 2021 May; 158():13-20. PubMed ID: 33587969
[TBL] [Abstract][Full Text] [Related]
4. Metabolite Biomarkers of Prolonged and Intensified Pain and Distress in Head and Neck Cancer Patients Undergoing Radio- or Chemoradiotherapy by Means of NMR-Based Metabolomics-A Preliminary Study.
Boguszewicz Ł; Heyda A; Ciszek M; Bieleń A; Skorupa A; Mrochem-Kwarciak J; Składowski K; Sokół M
Metabolites; 2024 Jan; 14(1):. PubMed ID: 38248863
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of Salivary Interleukin-6 in Patients with Oral Squamous Cell Carcinoma, Oral Potentially Malignant Disorders, Chronic Periodontitis and in Healthy Controls - A Cross-Sectional Comparative Study.
Rani NAJ; Vardhan BGH; Srinivasan S; Gopal SK
Ann Maxillofac Surg; 2023; 13(1):70-75. PubMed ID: 37711518
[TBL] [Abstract][Full Text] [Related]
6. TRP Channels in Tumoral Processes Mediated by Oxidative Stress and Inflammation.
Piciu F; Balas M; Badea MA; Cucu D
Antioxidants (Basel); 2023 Jun; 12(7):. PubMed ID: 37507867
[TBL] [Abstract][Full Text] [Related]
7. The Effects of Umbilical Cord Mesenchymal Stem Cells -Derived Exosomes in Oral Squamous Cell Carcinoma (In vitro Study).
Abdelwhab A; Alaa El-Din Y; Sabry D; Lotfy Aggour R
Asian Pac J Cancer Prev; 2023 Jul; 24(7):2531-2542. PubMed ID: 37505788
[TBL] [Abstract][Full Text] [Related]
8. Oxidative Stress and Inflammation Biomarkers in Postoperative Pain Modulation in Surgically Treated Patients with Laryngeal Cancer-Pilot Study.
Savic Vujovic K; Zivkovic A; Dozic I; Cirkovic A; Medic B; Srebro D; Vuckovic S; Milovanovic J; Jotic A
Cells; 2023 May; 12(10):. PubMed ID: 37408225
[TBL] [Abstract][Full Text] [Related]
9. Effect of CADM1 on TPF-induced chemotherapy in laryngeal squamous cell carcinoma.
Nie J; Li L; Tan F; Wang H; Wang H; Zou L; Wen Z
J Int Med Res; 2023 Apr; 51(4):3000605231168017. PubMed ID: 37114505
[TBL] [Abstract][Full Text] [Related]
10. Conditioned Media from Head and Neck Cancer Cell Lines and Serum Samples from Head and Neck Cancer Patients Drive Catabolic Pathways in Cultured Muscle Cells.
Saroul N; Tardif N; Pereira B; Dissard A; Montrieul L; Sanchez P; Salles J; Petersen JE; Jakobson T; Gilain L; Mom T; Boirie Y; Rooyakers O; Walrand S
Cancers (Basel); 2023 Mar; 15(6):. PubMed ID: 36980729
[TBL] [Abstract][Full Text] [Related]
11. Low Pretreatment Albumin-to-Globulin Ratios Predict Poor Survival Outcomes in Patients with Head and Neck Cancer: A Systematic Review and Meta-analysis.
Wang YT; Kuo LT; Lai CH; Tsai YH; Lee YC; Hsu CM; Liao CT; Kang CJ; Huang EI; Tsai MS; Chang GH; Tsai YT
J Cancer; 2023; 14(2):281-289. PubMed ID: 36741261
[No Abstract] [Full Text] [Related]
12. A circulating microRNA panel as a novel dynamic monitor for oral squamous cell carcinoma.
Piao Y; Jung SN; Lim MA; Oh C; Jin YL; Kim HJ; Nguyen QK; Chang JW; Won HR; Koo BS
Sci Rep; 2023 Feb; 13(1):2000. PubMed ID: 36737651
[TBL] [Abstract][Full Text] [Related]
13. Effect of regulatory cell death on the occurrence and development of head and neck squamous cell carcinoma.
Xue Y; Jiang X; Wang J; Zong Y; Yuan Z; Miao S; Mao X
Biomark Res; 2023 Jan; 11(1):2. PubMed ID: 36600313
[TBL] [Abstract][Full Text] [Related]
14. Genomic Immune Evasion: Diagnostic and Therapeutic Opportunities in Head and Neck Squamous Cell Carcinomas.
Kirtane K; St John M; Fuentes-Bayne H; Patel SP; Mardiros A; Xu H; Ng EW; Go WY; Wong DJ; Sunwoo JB; Welch JS
J Clin Med; 2022 Dec; 11(24):. PubMed ID: 36555876
[TBL] [Abstract][Full Text] [Related]
15. Suppression of TLR signaling by IRAK-1 and -4 dual inhibitor decreases TPF-resistance-induced pro-oncogenic effects in HNSCC.
Khan H; Pandey SN; Mishra A; Srivastava R
3 Biotech; 2023 Jan; 13(1):14. PubMed ID: 36540413
[TBL] [Abstract][Full Text] [Related]
16. Associations between patient-reported late effects and systemic cytokines in long-term survivors of head and neck cancer treated with radiotherapy.
Huynh TTM; Aass HCD; Falk RS; Astrup GL; Helland Å; Bjøro T; Bjordal K; Dale E; Hellebust TP; Herlofson BB; Malinen E; Kiserud CE; Osnes T; Amdal CD
J Cancer Surviv; 2023 Aug; 17(4):1082-1093. PubMed ID: 36350483
[TBL] [Abstract][Full Text] [Related]
17. Longitudinal Changes in the Fatty Acid Profile in Patients with Head and Neck Cancer: Associations with Treatment and Inflammatory Response.
Christou CN; Ehrsson YT; Westerbergh J; Risérus U; Laurell G
Cancers (Basel); 2022 Jul; 14(15):. PubMed ID: 35954360
[TBL] [Abstract][Full Text] [Related]
18. Immune Cell and Biochemical Biomarkers in Advanced Laryngeal Cancer.
Jotic A; Milovanovic J; Savic-Vujovic K; Radin Z; Medic B; Folic M; Pavlovic B; Vujovic A; Dundjerovic D
Dose Response; 2022; 20(3):15593258221115537. PubMed ID: 35898723
[TBL] [Abstract][Full Text] [Related]
19. Digesting the Role of JAK-STAT and Cytokine Signaling in Oral and Gastric Cancers.
Ni Y; Low JT; Silke J; O'Reilly LA
Front Immunol; 2022; 13():835997. PubMed ID: 35844493
[TBL] [Abstract][Full Text] [Related]
20. The Role of Immune Modulatory Cytokines in the Tumor Microenvironments of Head and Neck Squamous Cell Carcinomas.
Kondoh N; Mizuno-Kamiya M
Cancers (Basel); 2022 Jun; 14(12):. PubMed ID: 35740551
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
